iSpeak Blog
Global demand for plasma-derived therapies (PDTs) continues to swell—the compacting result of an aging population, clinical successes, and recent applications for both widespread diseases and multiple rare conditions. Serving these needs has been a significant challenge over the last two and a half years, with a decline in plasma donations due to the COVID-19 pandemic. The donation shortage...